7
Total investments
2
Early stage
3
Mid stage
1
Late stage
9y
Years active
Portfolio
7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Aug 2021
Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy (OutLast™), recruit a productive immune response in the tumor microenvironment (OutSmart™), and achieve the potency (OutSpacers™), specificity (Co-LOCKR™), and safety (EGFRopt™) necessary to unlock diverse cancer indications. Outpace’s internal and partnered pipeline approach is optimized for rapid clinical validation of its technologies across diverse cell types and manufacturing processes.
At Outpace Bio, we believe that the highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to building an open, diverse, and inclusive culture for all employees.
Board Member
Jan 2020
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia.
Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: www.inscopix.com
Board Member
Nov 2019
RightHand Robotics (RHR) is a leader in providing end-to-end solutions that reduce the cost of e-commerce order-fulfillment of electronics, apparel, grocery, pharmaceuticals, and countless other industries. Unlike traditional factory robots that can be complex to setup and are singly purposed, RHR solutions are simple to integrate and adaptable to improve the utilization of many different customer workflows, such as sorting batch-picked items, picking items from an ASRS, inducting items to a belt sorter, and order quality assurance.
Board Member
Oct 2018
Ayar Labs is transforming AI infrastructure by accelerating data movement. Recognizing that the complexity and size of AI models are increasing at a rate that traditional interconnect technology cannot handle, the company has developed the industry’s first co-packaged optics (CPO) solution that enables customers to maximize the compute efficiency and performance of growing AI infrastructure, while reducing costs, latency and power consumption. Based on open standards and optimized for both AI training and inference, Ayar Labs’ optical I/O solution is backed by a robust ecosystem that enables it to integrate smoothly into AI systems at scale.
Board Member
Dec 2017
Sparta Science Human Data Platform: where cutting-edge technology meets human potential. 🚀 We are at the forefront of revolutionizing human performance through advanced data-driven insights.
Our mission is clear – to empower individuals and organizations with AI-enabled actionable insights derived from data. By leveraging technology, we aim to unlock the full potential of human performance for large organizations.
Our commitment to excellence has led us to develop solutions that not only enhance performance but also provide actionable insights into keeping your team ready and on-the-job.
At Sparta Science, we believe in the power of data to transform lives. Our unique approach combines cutting-edge technology and AI, scientific expertise, and a passion for unlocking human potential. We are not just a company; we are a movement dedicated to fostering a culture of continuous improvement and resilience.
🌐 Company Overview:
Sparta Science, established in 2009, has been a trailblazer in the realm of human performance. Our journey began with a commitment to democratize force plate technology, making it accessible globally. Over the years, weve evolved with the industry and technology into a human data platform fueled by innovation and were reshaping the landscape of human measurement.
Join us on our journey as we continue to pioneer advancements in human measurement. Follow us for updates on the latest innovations, industry insights, and success stories.
Lets redefine whats possible together. 💪
Board Member
Aug 2017
Skydio’s mission is to make the world more productive, creative, and safe with autonomous flight. AI and computer vision are foundational to our products, allowing drones to fly autonomously and automatically capture and process data. Skydio drones help public safety agencies, federal government, and private companies serve their communities more safely and effectively by providing real-time access to information captured with high-powered cameras mounted on intelligent flying robots. Our drones support thousands of organizations, including every branch of the U.S. military, 26 allied nation, 1,000+ public safety agencies across every U.S. state, and 900+ utility providers.
Founded in 2014, Skydio designs, assembles, and supports its products in the U.S., with headquarters in San Mateo, CA, and manufacturing facilities in Hayward, CA. Skydio is the largest drone manufacturer in the U.S. and has shipped 55,000+ flying robots.
The company is backed by top investors and strategic partners, including Andreessen Horowitz, Linse Capital, Next47, IVP, Playground, and NVIDIA.
Experience · 10 entries
All (10)
Investments (7)
Founder (2)
Board (7)
2023
2021
Board Member
Aug 2021
Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy (OutLast™), recruit a productive immune response in the tumor microenvironment (OutSmart™), and achieve the potency (OutSpacers™), specificity (Co-LOCKR™), and safety (EGFRopt™) necessary to unlock diverse cancer indications. Outpace’s internal and partnered pipeline approach is optimized for rapid clinical validation of its technologies across diverse cell types and manufacturing processes.
At Outpace Bio, we believe that the highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to building an open, diverse, and inclusive culture for all employees.
2020
Board Member
Jan 2020
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia.
Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: www.inscopix.com
2019
Board Member
Nov 2019
RightHand Robotics (RHR) is a leader in providing end-to-end solutions that reduce the cost of e-commerce order-fulfillment of electronics, apparel, grocery, pharmaceuticals, and countless other industries. Unlike traditional factory robots that can be complex to setup and are singly purposed, RHR solutions are simple to integrate and adaptable to improve the utilization of many different customer workflows, such as sorting batch-picked items, picking items from an ASRS, inducting items to a belt sorter, and order quality assurance.
2018
Board Member
Oct 2018
Ayar Labs is transforming AI infrastructure by accelerating data movement. Recognizing that the complexity and size of AI models are increasing at a rate that traditional interconnect technology cannot handle, the company has developed the industry’s first co-packaged optics (CPO) solution that enables customers to maximize the compute efficiency and performance of growing AI infrastructure, while reducing costs, latency and power consumption. Based on open standards and optimized for both AI training and inference, Ayar Labs’ optical I/O solution is backed by a robust ecosystem that enables it to integrate smoothly into AI systems at scale.
Show all 10 entries ↓
Investment activity
2017–2023 · 7 investments
Recent (last 2 years)Earlier
